PhenoSwitch Bio Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $10K

  • Investors
  • 1

PhenoSwitch Bio General Information


Developer of a class of anti-cancer agents. The company designs and develops a chemical molecule that provides dual action on both cancer cell proliferation and change in identity, offering the healthcare industry with agents that have broad applicability in multiple stages of cancer as well as multiple cancer indications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Pittsburgh, PA
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PhenoSwitch Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator $10K 0000 Completed Startup
To view PhenoSwitch Bio’s complete valuation and funding history, request access »

PhenoSwitch Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Idea Foundry Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view PhenoSwitch Bio’s complete investors history, request access »